[1] 中华医学会.酒精性肝病治疗指南 (2010年修订版) [J].中华肝脏病杂志, 2010, 3 (18) :167-170.
|
[2]Bialek SR, Redd JT, Lynch A, et al.Chronic liver disease a-mong two American Indian patient populations in the south-western United States, 2000-2003[J].J Clin Gastroen-terol, 2008, 42 (7) :949-954.
|
[3]孟晓丹, 向国卿, 贺小虎, 等.肝硬化病因及临床特点分析178例[J].世界华人消化杂志, 2008, 16 (17) :1880-1884.
|
[4]刘阳, 刘德东, 迟宝荣.酒精性肝硬化合并肝炎病毒感染的临床特点[J].吉林医学, 2005, 26 (2) :158-159.
|
[5]张鸣, 沈薇.824例肝硬化病因及相关分析[J].重庆医学, 2006, 35 (5) :438-439, 441.
|
[6]Saito H, Masuda T, Tashita A, et al.Effect of ethanol onmouse hepatitis virus-induced cytotoxicity[J].J Gastroen-terol, 1996, 31 (5) :679-683.
|
[7]陈建, 赵卫东, 王敏, 等.乙型肝炎病毒对酒精性肝病易感性的影响[J].中华内科杂志, 2005, 44 (8) :611-612.
|
[8]陈建, 许建民, 王敏, 等.基因芯片检测乙醇对慢性乙型肝炎患者乙肝病毒多位点基因突变的研究[J].中国病理生理杂志, 2008, 24 (3) :573-576.
|
[9]Kim WH, Hong F, Jaruga B, et al.Hepatitis B virus X pro-tein sensitizes primary mouse hepatocytes to ethanol-andTNF-alpha-induced apoptosis by a caspase-3-depend-ent mechanism[J].Cell Mol Immunol, 2005, 2 (1) :40-48.
|
[10]虞朝辉, 陈卫星, 陈韶华, 等.嗜酒合并乙型肝炎病毒感染与转化生长因子B1表达水平的关系[J].中华消化杂志, 2004, 24 (3) :178-179.
|
[11]赵卫东, 朱建友, 陈建, 等.酒精对乙型肝炎病毒复制和基因表达的影响[J].临床医学, 2007, 27 (4) :75-77.
|
[12]Larkin J, Clayton MM, Liu J, et al.Chronic ethanol con-sumption stimulates hepatitis B virus gene expression andreplication in transgenic mice[J].Hepatology, 2001, 34 (4Pt 1) :792-797.
|
[1] | Yuanpeng MAO, Zhe YU, Aqian SONG, Hongshan WEI. From viral hepatitis to hepatocellular carcinoma: The role of exosomal microRNAs[J]. Journal of Clinical Hepatology, 2023, 39(2): 439-443. doi: 10.3969/j.issn.1001-5256.2023.02.030 |
[2] | Hui DENG, Bin ZHANG, Bin ZHU, Zhayier DILIHUMAER, Weixian WANG, Chunxia GUO, Dongliang YANG, Xin ZHENG, Junzhong WANG, Baoju WANG. Research advances in the role of gut microbiota in chronic hepatitis B, chronic hepatitis C, and related liver diseases[J]. Journal of Clinical Hepatology, 2022, 38(5): 1143-1147. doi: 10.3969/j.issn.1001-5256.2022.05.035 |
[3] | Yang MAN, Zhiyi LIN, Zhang MIAO, Lerong YAN, Xiao CHENG, Renyi JING, Rong BAI, Pingwen HUANG, Hongwei ZHANG, Xinyu PENG. Comorbidity of hepatic cystic echinococcosis with HBV/HCV infection, liver cirrhosis, and hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(3): 601-605. doi: 10.3969/j.issn.1001-5256.2022.03.020 |
[4] | Yu Zhe, Yang YongPing. Concurrent hepatitis D virus infection increases risk of hepatocellular carcinoma in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2020, 36(4): 944-947. doi: 10.3969/j.issn.1001-5256.2020.04.053 |
[5] | Li Wei, Xing HuiChun. Intestinal microflora and alcoholic liver disease[J]. Journal of Clinical Hepatology, 2019, 35(3): 481-484. doi: 10.3969/j.issn.1001-5256.2019.03.006 |
[6] | Wang YueJiao, Song HaiYan, Xing LianJun, Ji Guang, Zheng PeiYong. Pathogenesis of hepatocellular carcinoma induced by HBV and HCV infection[J]. Journal of Clinical Hepatology, 2017, 33(7): 1381-1386. doi: 10.3969/j.issn.1001-5256.2017.07.040 |
[7] | Gao GuangFu, Zhang ShuFeng, Wang ZhangWu, Gao HongWei. Clinical features of alcoholic liver disease: a clinical analysis of 206 cases[J]. Journal of Clinical Hepatology, 2017, 33(9): 1766-1768. doi: 10.3969/j.issn.1001-5256.2017.09.028 |
[8] | Zhao DanTong, Yan HuiPing, Liu YanMin, Huang ChunYang, Zhang HaiPing, Zhao Yan, Liao HuiYu. Clinical features and prognosis of patients with primary biliary cholangitis complicated by hepatitis virus infection[J]. Journal of Clinical Hepatology, 2017, 33(8): 1532-1536. doi: 10.3969/j.issn.1001-5256.2017.08.025 |
[9] | Dong Jing, Jiang JiaJi. Antiviral therapy for hepatitis virus-related hepatocellular carcinoma:current status and challenges[J]. Journal of Clinical Hepatology, 2017, 33(7): 1270-1273. doi: 10.3969/j.issn.1001-5256.2017.07.013 |
[10] | Jiang Yong, Wang ZeYu, Han Tao. Recommendation about United Kingdom National guideline on the management of the viral hepatitides A, B and C 2015[J]. Journal of Clinical Hepatology, 2016, 32(4): 633-638. doi: 10.3969/j.issn.1001-5256.2016.04.004 |
[11] | Qiao ChunPing, Chen YueXiang. Advances in study of the relationship between apoptosis and alcoholic liver disease[J]. Journal of Clinical Hepatology, 2012, 28(5): 386-390. |
[12] | Ceng MinDe. Introduction to the EASL Clinical Practical Guidelines: Management of alcoholic liver disease[J]. Journal of Clinical Hepatology, 2012, 28(8): 565-568. |
[13] | Ge HongYan, Chen Bo, Li YouTian. Protective effects of saikoside on rats with alcoholic liver disease[J]. Journal of Clinical Hepatology, 2012, 28(12): 945-947. |
[14] | Chen LiDong, Cheng Jun, Hong Yuan, Zhang LianFeng, Han Li, Guo Jiang. Construction of the prokaryotic expression vector of NS5ATP4A gene and its expression[J]. Journal of Clinical Hepatology, 2010, 26(4): 371-373. |
[15] | Zhang WenJie, Liu LiJun, Du ShaoCai, Li ChaoXia, Lu QingYun, Yang ShaoHua. The prevalence of hepatitis C virus genotype in Lanzhou area[J]. Journal of Clinical Hepatology, 2010, 26(3): 290-291+294. |
[16] | Yu LiJun, Chen ShiJun, Zhang JingYao, An Yong. Expression of interferon α/β receptor on the membranes of peripheral monocytes from patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2007, 23(3): 167-169. |
[18] | Wang ShaoXin, Gao Ge, Sheng ChuanLun. The clinical observation of the liver damage in hepatic virus carriers after renal transplantation[J]. Journal of Clinical Hepatology, 2004, 20(1): 19-20. |